Boardroom Alpha
S-1 primary document
AEMD · Registration Statement (Form S-1) · Filed June 22, 2026

Aethlon Medical IncS-1 exhibit

aethlon_ex107.htm
Filing Fee Exhibit

Ex-Filing Fees

CALCULATION OF FILING FEE TABLES

S-1

Aethlon Medical Inc.

Table 1: Newly Registered and Carry Forward Securities

                                           
Line Item Type   Security Type   Security Class Title   Notes   Fee Calculation
Rule
  Amount Registered   Proposed Maximum Offering
Price Per Unit
  Maximum Aggregate Offering Price   Fee Rate   Amount of Registration Fee
                                           
Newly Registered Securities
Fees to be Paid   Equity   Common Stock, $0.001 par value per share       457(o)   6,000,000   $ 2.00   $ 12,000,000.00   0.0001381   $ 1,657.20
Fees to be Paid   Equity   Common Stock Underlying Common Stock Warrants   (1)   Other   6,000,000     2.00     12,000,000.00   0.0001381     1,657.20
Fees to be Paid   Equity   Common Stock Underlying Pre-Funded Warrants   (2)   Other   6,000,000     0.0010     6,000.00   0.0001381     0.83
Fees to be Paid   Equity   Common Stock Underlying Placement Agent Warrants   (3)   Other   240,000   $ 2.00   $ 480,000.00   0.0001381   $ 66.29
                                           
Total Offering Amounts:   $ 24,486,000.00         3,381.52
Total Fees Previously Paid:               0.00
Total Fee Offsets:               0.00
Net Fee Due:             $ 3,381.52

__________________________________________
Offering Note(s)

(1) Represents shares of common stock issuable upon exercise of the Common Stock Warrants. Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(g) under the Securities Act. Pursuant to Rule 457(g) under the Securities Act, and solely for the purpose of calculating the registration fee, the proposed maximum offering price per share for Common Stock issuable upon the exercise of the Common Stock Warrants is $2.00, which is the exercise price for the Common Stock Warrants.
(2) Represents shares of common stock issuable upon exercise of the Pre-Funded warrants. Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(g) under the Securities Act. Pursuant to Rule 457(g) under the Securities Act, and solely for the purpose of calculating the registration fee, the proposed maximum offering price per share for Common Stock issuable upon the exercise of the Pre-Funded Warrants is $0.001, which is the exercise price for the Pre-Funded Warrants.
(3) Represents shares of common stock issuable upon exercise of the Placement Agent Warrants. Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(g) under the Securities Act. Pursuant to Rule 457(g) under the Securities Act, and solely for the purpose of calculating the registration fee, the proposed maximum offering price per share for Common Stock issuable upon the exercise of the Placement Agent Warrants is $2.00, which is the exercise price for the Placement Agent Warrants.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer